


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-12.32%
+2.74%
-3.38%
-2.18%
+72.29%
IMNM
Immunome
$22.44
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
IMNM Price Performance
$22.85 (-1.79%)
$18.13 (+23.77%)
$9.39 (+138.98%)
$9.4 (+138.72%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
Analysts perspectives on the stock desirability, trend direction and growth potential
IMNM has Extreme risk level
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Dec 01, 2025
Initiate
Buy
Truist Securities
Nov 18, 2025
Reiterate
Overweight
Stephens
Sep 22, 2025
Initiate
Buy
Goldman Sachs
What is IMNM current stock price?
What are IMNM stock strengths?
What is IMNM Risk Level?
What is IMNM market cap and volume?
What is IMNM current Stock IQ?
Should I buy IMNM stock right now?
Is IMNM a Strong Buy right now?
What does a 'Strong Buy' rating mean for IMNM?
What does a 'Strong Sell' rating mean for IMNM?
What factors influence IMNM's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-12.32%
+2.74%
-3.38%
-2.18%
+72.29%
IMNM
Immunome
Current Price
$22.44

IMNM Price Performance
$22.85 (-1.79%)
$18.13 (+23.77%)
$9.39 (+138.98%)
$9.4 (+138.72%)
IMNM Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
Analysts perspectives on the stock desirability, trend direction and growth potential
IMNM has Extreme risk level
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 01, 2025
Initiate
Buy
Truist Securities
Nov 18, 2025
Reiterate
Overweight
Stephens
Sep 22, 2025
Initiate
Buy
Goldman Sachs
IMNM Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
IMNM Latest Analysis
HC Wainwright & Co. Initiates Coverage of Immunome (IMNM) with Buy Recommendation. Fintel reports that on February 12 2026 HC Wainwright &. Co. initiated coverage of Immunome (NasdaqCM:IMNM) with a Buy recommendation. Analyst Price Forecast Suggests 50.12% Upside
Today
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IMNM Stock trends
IMNM Stock performance
IMNM Stock analysis
IMNM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.